title: Facial granulomatous nodules during etanercept treatment for psoriasis.
authors.forename: Mahtab
authors.initials: M
authors.lastname: Samimi
authors.forename: Gérard
authors.initials: G
authors.lastname: Lorette
authors.forename: Laurent
authors.initials: L
authors.lastname: Machet
authors.forename: Anne
authors.initials: A
authors.lastname: de Muret
authors.forename: Hervé
authors.initials: H
authors.lastname: Watier
authors.forename: Annabel
authors.initials: A
authors.lastname: Maruani
mesh_terms: D000328:Adult; D003875:Drug Eruptions / Q000209:etiology*; D000068800:Etanercept; D005148:Facial Dermatoses / Q000139:chemically induced*; D006099:Granuloma / Q000139:chemically induced*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007155:Immunologic Factors / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor; D012507:Sarcoidosis / Q000139:chemically induced*
chemical_list: D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept